Table 2 Characteristics of the IV and oral clarithromycin groups after propensity matching
Characteristics | IV macrolide | Oral macrolide | p-value |
|---|---|---|---|
N | 226 | 226 | |
Age | 71 (59–78) | 71 (62–79) | 0.5 |
Gender | 116 (51.3%) | 121 (53.5%) | 0.6 |
Confusion | 40 (17.7%) | 41 (18.1%) | 0.9 |
Respiratory rate | 30 (20–32) | 30 (20–33) | 0.7 |
SBP | 108 (91–129) | 108 (90–130) | 0.9 |
Temperature | 38 (37–38.4) | 38 (37–38.4) | 0.9 |
Pulse | 105 (90–120) | 105 (90–120) | 0.7 |
H+ | 38 (34–43.7) | 38 (34–43) | 0.4 |
Urea | 8.2 (6.4–11.7) | 8.5 (6.7–11.9) | 0.4 |
Sodium | 136 (133–138) | 136 (133–138) | 0.8 |
Glucose | 6.6 (5.7–8.0) | 6.9 (5.7–8.5) | 0.2 |
CRP | 231 (102–339) | 209 (94–352) | 0.7 |
WCC | 15.3 (11.5–20.0) | 15.1 (10.1–19.4) | 0.6 |
Albumin | 36 (32–39) | 36 (33–40) | 0.5 |
CURB-65 | 3 (2–3) | 3 (2–3) | 0.1 |